ArticleCells2023

Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies.

Eiji Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.